Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTATIS: tenecteplase versus alteplase for acute ischemic stroke thrombolysis
PACTR202202707050206Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire Hassan II
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenecteplase and tissue-plasminogen activator in ischemic stroke, sponsored by Centre Hospitalier Universitaire Hassan II. Primary endpoint: Modified Rankin Scale at day 90. Started Oct 2019; status: recruiting.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on PACTR202202707050206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202707050206.